English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Singapore Scientists Discover New Pathways Leading to Cancer Progression
Jul 18, 2016 10:00 HKT
Study Finds Strong Genetic Risk Factor for Kidney Disease
Jul 13, 2016 10:00 HKT
A New Way to Diagnose and Treat Lung Cancer
Jul 12, 2016 10:00 HKT
Hepatitis B Clinical Trial opens in Australia
Jul 12, 2016 06:00 HKT
A New Way of Looking at Cancer
Jul 08, 2016 16:00 HKT
Nanobiotix Reports Successful Results from Phase I/II Trial of NBTXR3 in Head & Neck Cancer
Jul 07, 2016 11:00 HKT
Neste Jacobs Playing a Major Role in Asia's Largest Biopharma Project
Jun 29, 2016 15:00 HKT
Uni-Bio Science Group Announces 2015 Annual Results
Jun 14, 2016 08:06 HKT
TANAKA develops ZIKA virus detection kit
Jun 07, 2016 10:00 HKT
New Material Kills E. Coli Bacteria in 30 Seconds
Jun 03, 2016 10:00 HKT
Nanobiotix Establishes Promising Preclinical Proof-of-Concept in Immuno Oncology
May 31, 2016 14:20 HKT
Real-Time Imaging of Embryo Development Could Pave the Way for More Effective Human Reproduction Therapies
May 20, 2016 15:00 HKT
NT Pharma's Acquisition of Novartis's Well-known International Orthopedic Brand Miacalcic Helps to Enrich Product Portfolio and Enhance Profitability
May 18, 2016 23:55 HKT
Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology
May 16, 2016 13:40 HKT
New Technique Paves the Way for Drug Targeting to Fight Microbial Resistance
May 13, 2016 11:00 HKT
Scientists Discover New Technology Breakthrough in Fighting Viral Diseases
May 11, 2016 21:00 HKT
Luye Medical welcomes Australia's Healthe Care to its Group
May 06, 2016 12:00 HKT
Hong Kong International Medical Devices and Supplies Fair Opens
May 03, 2016 18:00 HKT
Nanobiotix: 2015 Annual Results
Apr 29, 2016 15:00 HKT
Shanghai Pharmaceuticals Released 2016 Q1 Results
Apr 29, 2016 08:21 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: